The Europe Artificial Intelligence In Precision Medicine Market would witness market growth of 32.4% CAGR during the forecast period (2022-2028).
The digital revolution has significantly transformed the healthcare industry. Care delivery and system performance are the areas that have best shown how innovation and integration have aided change. As a result of the ability to effortlessly incorporate new technologies like AI, IoT, and ML due to digital convergence, the next wave of revolution in healthcare is already creating the foundation for a customer-driven business model.
One of the most exciting and potentially game-changing opportunities for the life sciences sector is AI. In the upcoming years, it will be a top investment target as other businesses want to take advantage of its potential. Investors are anticipated to enter the AI market early, and the number of applications is anticipated to rise further.
The fastest-growing neurological condition is Parkinson's disease. The progression of the disease has not yet been stopped or reversed by any medicine. The development of PD drugs and the management of the condition are significantly hampered by the lack of accurate diagnostic biomarkers. Clinical signs, mostly involving motor functions, including rigidity and tremor, are commonly used to diagnose the condition. However, motor symptoms frequently don't show up until years after the disease first manifests, which delays diagnosis. The regional market for artificial intelligence in precision medicine is being driven by these factors.
The Germany market dominated the Europe Artificial Intelligence in Precision Medicine Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $447 Million by 2028.The UK market is anticipated to grow at CAGR of 31.2% during (2022 - 2028). Additionally, The France market would exhibit a CAGR of 33.3% during (2022 - 2028).
Based on Application, the market is segmented into Oncology, Cardiology, Neurology, Respiratory and Others. Based on Component, the market is segmented into Software, Hardware and Service. Based on Technology, the market is segmented into Deep Learning, Natural Language Processing, Querying Method and Context Aware Processing. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
Free Valuable Insights: The Global Artificial Intelligence In Precision Medicine Market will Hit $6.3 Billion by 2028, at a CAGR of 32.6%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include General Electric (GE) Co. (GE Healthcare), Sanofi S.A., NVIDIA Corporation, Intel Corporation, Microsoft Corporation, IBM Corporation, Google LLC (Alphabet Inc.), AstraZeneca PLC, and Tempus, Inc.
By Application
By Component
By Technology
By Country
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
